(Q44689726)

English

Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations

scientific article published in July 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations (English)

1 reference

Europe PubMed Central

5 December 2017

endometrial carcinoma

1 reference

based on heuristic

inferred from title

Camilla Krakstad

8

1 reference

Europe PubMed Central

5 December 2017

10

1 reference

Europe PubMed Central

5 December 2017

22

object named as

L A Akslen

1 reference

Europe PubMed Central

5 December 2017

2

object named as

J Trovik

1 reference

Europe PubMed Central

5 December 2017

Andrew D Cherniack

19

object named as

A D Cherniack

1 reference

Europe PubMed Central

5 December 2017

author name string

E Wik

1

1 reference

Europe PubMed Central

5 December 2017

K Kusonmano

3

1 reference

Europe PubMed Central

5 December 2017

E Birkeland

4

1 reference

Europe PubMed Central

5 December 2017

M B Raeder

5

1 reference

Europe PubMed Central

5 December 2017

I Pashtan

6

1 reference

Europe PubMed Central

5 December 2017

E A Hoivik

7

1 reference

Europe PubMed Central

5 December 2017

H M J Werner

9

1 reference

Europe PubMed Central

5 December 2017

S Mjøs

11

1 reference

Europe PubMed Central

5 December 2017

M K Halle

12

1 reference

Europe PubMed Central

5 December 2017

M Mannelqvist

13

1 reference

Europe PubMed Central

5 December 2017

K K Mauland

14

1 reference

Europe PubMed Central

5 December 2017

A M Oyan

15

1 reference

Europe PubMed Central

5 December 2017

I M Stefansson

16

1 reference

Europe PubMed Central

5 December 2017

K Petersen

17

1 reference

Europe PubMed Central

5 December 2017

R Simon

18

1 reference

Europe PubMed Central

5 December 2017

M Meyerson

20

1 reference

Europe PubMed Central

5 December 2017

K H Kalland

21

1 reference

Europe PubMed Central

5 December 2017

H B Salvesen

23

1 reference

Europe PubMed Central

5 December 2017

language of work or name

0 references

publication date

1 July 2014

1 reference

Europe PubMed Central

5 December 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

5 December 2017

134

1 reference

Europe PubMed Central

5 December 2017

3

1 reference

Europe PubMed Central

5 December 2017

599-606

1 reference

Europe PubMed Central

5 December 2017

Markers for individualised therapy in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

High accordance in prognosis prediction of colorectal cancer across independent datasets by multi-gene module expression profiles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Lung metastasis genes couple breast tumor size and metastatic spread.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Taming the dragon: genomic biomarkers to individualize the treatment of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Integrated genomic characterization of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Stratification based on high tumour cell content in fresh frozen tissue promotes selection of aggressive endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Airway PI3K pathway activation is an early and reversible event in lung cancer development

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Expression profiling of epithelial plasticity in tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Gene expression phenotypic models that predict the activity of oncogenic pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Comprehensive molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Emerging therapeutic targets in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Reporting recommendations for tumor marker prognostic studies (REMARK).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

The Nance-Horan syndrome protein encodes a functional WAVE homology domain (WHD) and is important for co-ordinating actin remodelling and maintaining cell morphology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

A comparative and integrative approach identifies ATPase family, AAA domain containing 2 as a likely driver of cell proliferation in lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

The PI3K pathway as drug target in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Epithelial-mesenchymal transition in cancer development and its clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Is the epithelial-to-mesenchymal transition clinically relevant for the cancer patient?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.06.026

7 January 2021

Identifiers

10.1016/J.YGYNO.2014.06.026

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44689726&oldid=2032244176"